Korean Market
EXCH
HLB innoVation
★

HLB innoVation Adjusts Conversion Price of 3rd CB Down 23.7%, Limited Dilution Impact

 
EXCH
HLB innoVation
★

HLB innoVation to Conduct NDR for Overseas Institutional Investors Focusing on Subsidiary Verismo Therapeutics to Enhance Corporate Value

 
OWNR
HLB innoVation
★

HLB Maintains Majority Stake in HLB innoVation at 36.57%, Slight Change Due to Exclusion of Special Relations

 
EXCH
HLB innoVation
★

HLB InnoVation Changes CEO Due to Personal Reasons; Jin Yanggon Appointed

 
PERI
HLB innoVation
★

HLB innoVation Amends Annual Report to Include Financial Supervisory Service Warning, No Financial or Shareholder Value Impact

 
EXCH
HLB innoVation
★

HLB innoVation Decides to Invest Additional KRW 41.4 Billion in US Subsidiary VERISMO for Clinical Trials, No Dilution to Existing Shareholders

 
EXCH
HLB innoVation
★

HLB InnoVation Holds NDR for Verismo Therapeutics Subsidiary, Limited Stock Price Impact

 
EXCH
HLB innoVation
★

HLB innoVation to Hold NDR for Verismo Therapeutics Business Presentation - Aimed at Enhancing Institutional Investor Understanding, Limited Stock Price Impact

 
OWNR
HLB innoVation
★

HLB Innovation Director Jin Yang-gon Increases Stake to 0.69% via Open Market Purchase, Signaling Management Confidence

 
OWNR
HLB innoVation
★

HLB Increases Stake in HLB innoVation by 0.12%, Strengthening Control as Largest Shareholder

 
OWNR
HLB innoVation
★

HLB slightly increases stake in HLB innoVation by 0.01% through open market purchase, reinforcing control with minimal price and dilution impact

 
EXCH
HLB innoVation
★

HLB innoVation to Hold NDR for Subsidiary Verismo Therapeutics Business Update - Neutral Impact on Shareholder Value

 
OWNR
HLB innoVation
★

CEO Yoon Jong-sun of HLB innoVation Acquires 3,000 Shares via Open Market Purchase, Insider Ownership Rises Marginally to 0.01%

 
PERI
HLB innoVation
★

HLB Innovation: 2025 Consolidated Operating Loss Widens to KRW 37.6B, Separate Entity Turns Profitable; Issued KRW 33B CB for Bio R&D Funding

 
EXCH
HLB innoVation
★

HLB innoVation to Hold NDR for Institutional Investors from June 1-5, Discuss Subsidiary Verismo